Glintborg, B, Juul Sørensen, I, Vendelbo Jensen, D, Krogh, NS, Loft, AG, Colic, A, Espesen, J, Olsen, J
, Hendricks, O, Grydehøj, J, Jensen Hansen, IM, Sørensen, MV
, Chrysidis, S, Manilo, N, Klarlund, M, Andersen, LS, Nordin, H, Kristensen, S & Hetland, ML 2016, '
Three months* clinical outcomes from a Nationwide Non-Medical Switch from originator to biosimilar infliximab in patients with inflammatory artrhritis. Results from the Danbio registry', EULAR 2016, London, United Kingdom,
08/06/2016 -
11/06/2016.